Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Galectin Therapeutics Inc has 8 disclosed suppliers and 1 disclosed customer. Each one is named in an SEC filing, either Galectin Therapeutics Inc’s own annual report or the counterparty’s, and carries the sentence that discloses it.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“The trial did not meet its primary endpoint as measured using multi-parametric magnetic resonance imaging (LiverMultiScan (R) , Perspectum Diagnostics).”
FILING10-K0001140361-26-012155cik 0001133416
“We have contracted with Covance (now known as Fortrea) for assistance with the design and conduct of our NAVIGATE trial.”
FILING10-K0001140361-26-012155cik 0001133416
“Late in 2021, we engaged three noted physicians – Dr. Chetan Bettegowda, from Johns Hopkins, and Dr. Nishant Agrawal and Dr. Ari Rosenberg, both from University of Chicago Medical Center – as consultants to help define the path forward in oncology.”
FILING10-K0001140361-26-012155cik 0001133416
“Late in 2021, we engaged three noted physicians – Dr. Chetan Bettegowda, from Johns Hopkins, and Dr. Nishant Agrawal and Dr. Ari Rosenberg, both from University of Chicago Medical Center – as consultants to help define the path forward in oncology.”
FILING10-K0001140361-26-012155cik 0001133416
“Late in 2021, we engaged three noted physicians – Dr. Chetan Bettegowda, from Johns Hopkins, and Dr. Nishant Agrawal and Dr. Ari Rosenberg, both from University of Chicago Medical Center – as consultants to help define the path forward in oncology.”
FILING10-K0001140361-26-012155cik 0001133416
“As of December 31, 2025, Mr. Uihlein has provided us with a line of credit and has made significant equity investments in the Company.”
FILING10-K0001140361-26-012155cik 0001133416
“In 2023, we received $30,000,000 in proceeds under a convertible line of credit provided by our chairman in addition to $10 million in proceeds from stock purchase warrants exercised by our chairman.”
FILING10-K0001140361-26-012155cik 0001133416
“We have filed a shelf registration statement to allow registered sales by us of up to $100 million, which includes the offer and sell shares of our common stock having an aggregate offering price of up to $35,967,000 from time to time pursuant to our At The Market Issuance Sales Agreement with H.C. Wainwright & Co., LLC.”
FILING10-K0001140361-26-012155cik 0001133416
“These studies were conducted under the sponsorship of Providence Portland Medical Center's Earle A. Chiles Research Institute (EACRI).”
FILING10-K0001140361-26-012155cik 0001133416
Watchlist prices, news filtered to it, and its next report on your desk.
GALT (Galectin Therapeutics Inc) has 8 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Galectin Therapeutics Inc
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 3.69 · gapped above the open, then crossed back over prior close. High/low 3.78 at 9:30 am ET, 3.61 at 11:00 am ET.